about
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenMicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseasesGenetic determinants for methotrexate response in juvenile idiopathic arthritisAmelioration of 4'-epidoxorubicin-induced cardiotoxicity by sodium cromoglycateFate of lymphocytes after withdrawal of tofacitinib treatmentIdentification of P-glycoprotein at the membrane of mast cell secretory granules. An immunofluorescence and protein A-gold electron microscopical investigation.Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome.Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone.PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicityPersonalized therapies in pediatric inflammatory and autoimmune diseases.Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.Pharmacogenomic approaches for tailored anti-leukemic therapy in children.Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress.Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives.Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy.Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.The effect of clodronate on a mevalonate kinase deficiency cellular model.The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies.The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells.Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes.Fasting increases tobramycin oral absorption in miceRole of inosine triphosphate pyrophosphatase gene variant on fever incidence during zidovudine antiretroviral therapy.Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy. Function of bilitranslocase.Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells.Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. Multidrug transporters in the LLC-PK(1) cell line and its resistant counterpart.Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport.Endocytosis of gentamicin in a proximal tubular renal cell line.Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice.Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia.Effect of polyethylene glycol 400 on adriamycin toxicity in mice.Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM - induced cardiomyopathy.Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease.
P50
Q26798470-50878472-C2D4-4104-8549-ED91614672E8Q27011618-508C5722-4837-4697-BB4D-31227987CF57Q27026473-61D0182D-F4A9-49AC-8693-91F2C8A7DD18Q28339599-AC9E0402-7301-4406-BD45-B741E5F0A600Q28538586-09CC9D3A-04E3-4658-8167-0153144A8867Q32116219-A94E4BEE-CDD2-4F26-BCAF-1F3FC60096E2Q34413976-8DACE397-4E62-4C2D-9473-74F54E621771Q34519514-7329747C-4EB9-4AFB-9259-C6BEE8827975Q35221802-50ECCB3C-AF93-46AB-98E6-294F4665A085Q35375821-D3D720AA-2107-4583-84AB-D9071211C1C1Q36036407-9F5DD3C3-F29F-4097-B0A5-C83C13597548Q36317718-819E4F21-D915-4320-8D72-0A2A7A52AE82Q38020984-FC68DBFE-1324-4FC7-97F7-B4B553761E9EQ38075561-AEDDECE6-C70D-4704-A1C1-5868DAEF5215Q38086321-18E4ADE7-F625-43D0-8A0F-3AB44D11275DQ38440563-D6CE449D-9491-4DAD-B401-E176C16C516BQ38595273-B5006E07-C28F-4823-B07B-EB9A7E077CC6Q38620025-74C9C9B7-7ABD-47FC-98D5-A1891EF054B1Q38758251-28FAE72F-C286-4692-A7C2-C02F0092E302Q38770331-37EF3C1D-5E11-49BA-A72D-B0E72CF24227Q38788926-6EE393CE-CAF1-4BA2-8713-3368B2094640Q38912329-63228130-99BB-4004-A034-A922907E31AEQ39304480-FD3E47A4-2CD4-4E02-9296-0B3457DDA4DBQ39454397-D76BF48F-562D-4389-B9D2-13B413F6D1F8Q39571798-E001CAA2-6900-4CA9-B4DB-C242A84DDFB4Q39701251-DF8AA27B-8EEF-4D83-AADB-461DA36D68B7Q39769170-9C565A20-17A6-4F52-979F-67C099C007D4Q39895437-4F521214-7F00-49BC-8948-5BC07AC8E5AEQ40071549-950FCD40-A420-44E4-A9D4-BB0F08C4CF82Q40355836-47F5B3FC-7892-4A32-9359-10C4F6DE4221Q40601704-075D18E5-8CA7-4333-B533-B384A313F888Q40834685-56A1E6C8-36B4-408D-93E2-02C064B194A0Q40915648-D06F46C1-4BC2-41A3-B735-0217E9FF57FEQ40926086-B3A75C5E-E389-4E18-92A4-3A43A70E2DF6Q41068390-F02687CC-1DE8-4F42-9014-06E0FCAFFE3AQ42203878-04C24DBF-8A62-499D-A636-5B3CE93C73B0Q42251620-BBAF5F0D-F518-4B61-A3EA-7C92AF56CF7CQ42251624-8392A69A-7C16-4674-B4AE-789A268E4F4AQ42269807-425CA22D-1ED3-4B31-A8E3-CD2940D0E30FQ42409995-67D11010-F06F-4CA0-9C7D-9CC4C799A908
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giuliana Decorti
@ast
Giuliana Decorti
@en
Giuliana Decorti
@es
Giuliana Decorti
@nl
Giuliana Decorti
@sl
type
label
Giuliana Decorti
@ast
Giuliana Decorti
@en
Giuliana Decorti
@es
Giuliana Decorti
@nl
Giuliana Decorti
@sl
prefLabel
Giuliana Decorti
@ast
Giuliana Decorti
@en
Giuliana Decorti
@es
Giuliana Decorti
@nl
Giuliana Decorti
@sl
P106
P1153
56253997100
P21
P31
P496
0000-0002-9714-6246